Endogenous Cushing's Syndrome: Clinical Trials

2 trials for Endogenous Cushing's Syndrome, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 32Completed 2

Follow Endogenous Cushing's Syndrome: new trials by email Literature Review of Endogenous Cushing's Syndrome trials Research Report on Endogenous Cushing's Syndrome

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study to Assess the Safety and Efficacy of Levoketoconazole in the Treatment of Endogenous Cushing's Syndrome.
Levoketoconazole, Placebo - Endogenous Cushing's Syndrome
Phase 3CompletedCortendo AB842017-09-262022-11-08
Treatment for Endogenous Cushing's Syndrome
Levoketoconazole - Endogenous Cushing's Syndrome
Phase 3CompletedCortendo AB942014-08-012021-04-19

Narrower conditions

Adrenocortical Hyperfunction (1)  ·  Cushing Syndrome (1)  ·  Pituitary ACTH Hypersecretion (1)

Broader conditions

Endocrine System Diseases (2)  ·  Adrenal Gland Diseases (1)  ·  Brain Diseases (1)  ·  Central Nervous System Diseases (1)  ·  Hyperpituitarism (1)  ·  Hypothalamic Diseases (1)  ·  Nervous System Diseases (1)  ·  Pituitary Diseases (1)

Sponsors

Cortendo AB (2)

Countries

Bulgaria (2)  ·  Denmark (2)  ·  France (2)  ·  Israel (2)  ·  Italy (2)  ·  Netherlands (2)  ·  Poland (2)  ·  Spain (2)  ·  United States (2)  ·  Belgium (1)  ·  Canada (1)  ·  Czechia (1)  ·  Germany (1)  ·  Greece (1)  ·  Hungary (1)

Top investigators

Fredric J Cohen, MD (1)  ·  Xavier Valencia, MD (1)

Results publications

PMID 31542384, PMID 33216275, PMID 33897615